Open AccessTesting a novel peptide drug towards a goal of reducing mortality in critically ill COVID19 patients
Author(s) -
Aleyna Celebi,
Nisa Celebi,
Matthew P. Hirakawa,
Yooli Kim Light,
Raga Krishnakumar
Publication year - 2020
Publication title -
osti oai (u.s. department of energy office of scientific and technical information)
Language(s) - English
Resource type - Reports
DOI - 10.2172/1673818
Subject(s) - cytokine storm , immune system , critically ill , covid-19 , cytokine , medicine , drug , intensive care medicine , disease , immunology , pharmacology , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom